NextCure logo
NextCure NXTC
$ 7.0 0.55%
report update icon

Quarterly report 2026-Q2
added 08-06-2026

NextCure Gross Profit | NXTC

Gross profit is a key indicator of how efficiently a company produces or sells its products. This metric helps assess a business’s ability to generate revenue at the initial stage, before accounting for all other expenses. Regular analysis of gross profit allows companies to respond in a timely manner to changes in cost of goods, pricing strategy, and market conditions.

Calculation formula:
Gross Profit = Revenue – Cost of Goods Sold (COGS)

Revenue — all cash inflows from the sale of goods or services.
Cost of Goods Sold — direct costs related to the production or acquisition of goods:
  • Raw materials and supplies
  • Wages of production personnel
  • Depreciation of equipment
  • Transportation and warehousing costs (if directly related to production)
Importance for business:
  • Assessing core business profitability
    If gross profit is declining, it may indicate rising production costs or falling sales.
  • Financial planning
    Gross profit is the basis for calculating other key metrics, such as operating and net profit.
  • Benchmarking against competitors
    Gross profit analysis helps compare the efficiency of different companies within the same industry.
  • Insights into pricing effectiveness
    If gross profit is low, the company may be pricing too low or failing to control costs effectively.
Reasons for a decline in gross profit:
  • Increase in raw material and supply costs
  • Rising production expenses
  • Price reductions due to competition
  • Decrease in sales volume
  • Currency exchange rate fluctuations (for imports/exports)

Gross profit is an important metric, but it does not provide a complete picture of a company’s financial health, as it does not account for administrative and selling expenses, taxes, debt burden, or depreciation.

Annual Gross Profit NextCure

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
- - - - - 22.4 K - - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
22.4 K 22.4 K 22.4 K

Gross Profit of other stocks in the Biotechnology industry

Issuer Gross Profit Price % 24h Market Cap Country
Фармсинтез Фармсинтез
LIFE
160 M - - - russiaRussia
AbbVie AbbVie
ABBV
12.1 B $ 257.12 0.86 % $ 455 B usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
90 K - - $ 7.46 M israelIsrael
Amryt Pharma plc Amryt Pharma plc
AMYT
116 M - - $ 621 M britainBritain
ASLAN Pharmaceuticals Limited ASLAN Pharmaceuticals Limited
ASLN
12 M - -14.27 % $ 1.7 M singaporeSingapore
Acorda Therapeutics Acorda Therapeutics
ACOR
119 M - -24.86 % $ 820 K usaUSA
Adaptimmune Therapeutics plc Adaptimmune Therapeutics plc
ADAP
1.12 M - -15.15 % $ 60.3 M britainBritain
Advaxis Advaxis
ADXS
90 K - -9.65 % $ 45.9 M usaUSA
Abeona Therapeutics Abeona Therapeutics
ABEO
925 K $ 5.42 0.18 % $ 287 M usaUSA
Albireo Pharma Albireo Pharma
ALBO
39.2 M - -0.23 % $ 916 M usaUSA
BioXcel Therapeutics BioXcel Therapeutics
BTAI
24.3 $ 0.07 9.81 % $ 855 K usaUSA
Cyclerion Therapeutics Cyclerion Therapeutics
CYCN
2.3 M $ 23.52 458.67 % $ 98.9 M usaUSA
Lexicon Pharmaceuticals Lexicon Pharmaceuticals
LXRX
319 M $ 2.0 0.3 % $ 726 M usaUSA
Arbutus Biopharma Corporation Arbutus Biopharma Corporation
ABUS
-40.6 M $ 5.12 0.1 % $ 981 M canadaCanada
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
-523 K - -11.43 % $ 502 K usaUSA
Aridis Pharmaceuticals Aridis Pharmaceuticals
ARDS
1 K - 17.91 % $ 11.1 M usaUSA
ACADIA Pharmaceuticals ACADIA Pharmaceuticals
ACAD
473 M $ 27.83 0.32 % $ 4.69 B usaUSA
SQZ Biotechnologies Company SQZ Biotechnologies Company
SQZ
21 M - 57.95 % $ 12.8 M usaUSA
Berkeley Lights Berkeley Lights
BLI
53.8 M - -7.31 % $ 87 M usaUSA
Achieve Life Sciences Achieve Life Sciences
ACHV
18.2 M $ 7.06 0.41 % $ 308 M usaUSA
Baudax Bio Baudax Bio
BXRX
-1.24 M - 0.59 % $ 63 K usaUSA
Codiak BioSciences Codiak BioSciences
CDAK
2.92 K - -55.98 % $ 2.15 M usaUSA
ChemoCentryx ChemoCentryx
CCXI
64.9 M - - $ 3.74 B usaUSA
Avid Bioservices Avid Bioservices
CDMO
7.32 M - - $ 789 M usaUSA
Cerevel Therapeutics Holdings Cerevel Therapeutics Holdings
CERE
-2.55 M - - $ 7.29 B usaUSA
Aclaris Therapeutics Aclaris Therapeutics
ACRS
172 K $ 5.32 1.27 % $ 652 M usaUSA
Checkpoint Therapeutics Checkpoint Therapeutics
CKPT
1.07 - - $ 169 M usaUSA
ADMA Biologics ADMA Biologics
ADMA
293 M $ 9.23 0.16 % $ 2.2 B usaUSA
Adaptive Biotechnologies Corporation Adaptive Biotechnologies Corporation
ADPT
62.8 M $ 24.2 0.08 % $ 3.67 B usaUSA
Agenus Agenus
AGEN
-18.3 M $ 6.94 0.73 % $ 206 M usaUSA
Agios Pharmaceuticals Agios Pharmaceuticals
AGIO
117 M $ 33.6 0.16 % $ 1.95 B usaUSA